Innovative Health launches B2B platform for at-home testing

LabPulse.com staff writers
Sep 20, 2022
2020 05 15 22 29 3148 Test Tube Liquid Sample 400

Innovative Health Diagnostics has launched a diagnostic-as-a-service (DaaS) platform that enables brands to offer at-home testing for initial diagnostics and recurring testing.

Digital health organizations can utilize Innovative Health's partner platform to offer consumers more than 70 different at-home tests that detect conditions, including infectious diseases and women's and men's health concerns, the firm said.

Latest in Women's Health
2019 07 03 22 37 5166 Heart 400
Study to use genetic testing to evaluate heart disease
February 22, 2022
2022 02 01 23 59 3100 Home Smarthome Icon2 400
Labcorp launches online portal for patients
February 3, 2022
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
2019 10 09 17 32 0093 Dna Cancer Cell 400
Hologic buys Biotheranostics molecular testing firm
January 4, 2021
Related Stories
Lab Blood Samples 400
Point-of-Care Testing
Getlabs, JumpstartMD partner to provide at-home phlebotomy
2020 01 21 22 13 2411 Virus Coronavirus 400
Infectious
Innovative Health Dx launches at-home, DTC diagnostic tests
2022 08 24 19 47 7252 Endometriosis 400
Point-of-Care Testing
IHD, AIMA to develop at-home endometriosis test
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Women's Health
Study to use genetic testing to evaluate heart disease
By LabPulse.com staff writers
Researchers from Dignity Health's Chandler Regional Medical Center, Mercy Gilbert Medical Center, and St. Joseph's Hospital and Medical Center will gather approximately 2,000 DNA samples from men and women between the ages of 40 and 60 with no known history of heart disease. The samples will be analyzed for genetic markers known to cause heart disease at Baylor College of Medicine's Human Genome Sequencing Center Clinical Lab in Houston.
February 22, 2022
2019 07 03 22 37 5166 Heart 400
Labcorp launches online portal for patients
By LabPulse.com staff writers
The OnDemand portal includes a suite of Labcorp's most popular tests, including for wellness, allergy, COVID-19, and women's health and fertility. The company is planning to add additional tests to Labcorp OnDemand later this year.
February 3, 2022
2022 02 01 23 59 3100 Home Smarthome Icon2 400
Labcorp acquires women's digital health firm Ovia
By LabPulse.com staff writers
Ovia has developed a software platform designed to help individuals manage parenting and women's and family health. It includes features like reproductive cycle tracking, baby growth tracking, and fertility and pregnancy support.
August 12, 2021
2020 10 14 15 59 9456 Business Woman Handshake 400
Hologic buys Biotheranostics molecular testing firm
By LabPulse.com staff writers
Acquiring Biotheranostics allows Hologic to enter the fast-growing oncology molecular testing market, according to the firm. It also fits well with the company's existing focus on women's health.
January 4, 2021
2019 10 09 17 32 0093 Dna Cancer Cell 400
Canadian researchers develop test to track dietary fats
By LabPulse.com staff writers
The test could help nutritional epidemiologists develop better guidelines for dietary fat consumption, especially for specific populations such as pregnant women, whose fat intake can affect the health of their babies, according to a team led by Philip Britz-McKibbin, PhD.
May 18, 2020
2020 05 18 20 32 3350 Omega 3 Fats 400
New POC test performs well for chlamydia, gonorrhea in women
By Emily Hayes
The multisite study evaluated tests for the two common sexually transmitted infections (STIs) on Binx Health's benchtop polymerase chain reaction (PCR) instrument, which delivers results in 30 minutes. The U.S. Food and Drug Administration (FDA) approved use of the instrument in men last month, following clearance for use in women in August 2019. Validation data supporting the regulatory clearances were published by Johns Hopkins epidemiologist Charlotte Gaydos and colleagues.
May 14, 2020
2019 06 11 20 36 8064 Neisseria Gonorrhoeae Gonorrhea 400
Older women benefit from genetic breast cancer testing
By Kate Madden Yee
The study addresses the question of who exactly should undergo breast cancer genetic testing, wrote a team led by Dr. Allison Kurian of Stanford University.
March 10, 2020
2020 03 09 22 32 4662 Doctor Woman Patient Older 400
Opioid use doesn't prevent women from cancer screening
By LabPulse.com staff writers
The findings speak to the concern that addressing patients' pain with opioid medications may diminish compliance with preventive health measures such as cancer screening, wrote a team led by Dr. Alicia Agnoli of the University of California, Davis (Ann Fam Medicine, January/February 2020, Vol. 18:1, pp. 59-65).
February 18, 2020
2018 02 23 23 54 4956 Bottle Pills 400
Could cervical cancer be eliminated in 20 years?
By Kate Madden Yee
The findings suggest a way for the U.S. clinical community to actively respond to the World Health Organization's (WHO) 2018 charge to eliminate cervical cancer as a public health problem, wrote a team led by Emily Burger, PhD, of the Harvard T.H. Chan School of Public Health in Boston. The WHO's cervical cancer incidence target is four or fewer cases per 100,000 women-years.
February 10, 2020
2019 05 17 20 14 3434 Uterus Cervix 400
Hormone blood test could pinpoint time of menopause
By Emily Hayes
The investigators explored the potential of the picoAMH enzyme-linked immunosorbent assay (ELISA) research-use-only product (Ansh Labs) using data for 1,537 middle-aged women enrolled in the prospective, longitudinal Study of Women's Health Across the Nation (SWAN). Among many other kinds of health assessments tracked over time during the menopause transition period, SWAN entailed blood testing for AMH, an ovarian hormone, and follicle-stimulating hormone (FSH), a pituitary hormone.
January 22, 2020
2019 05 13 16 12 9218 Lab Blood Woman2 400
Smartphones double as point-of-care diagnostics
By Joseph Constance
The technical capabilities of these phones have become so advanced that they can compete with technology once thought to be only the domain of physicians' offices and hospitals. Research groups and startup companies are developing apps and technology that turn smartphones into tools that can diagnose eye disease, perform home-based urinalysis, diagnose ear infections and respiratory disease, and help women learn about their reproductive health.
December 1, 2019
2019 12 01 00 02 8839 Remidio Field Use 20191201002201
Breast cancer risk scores need to be adapted for men
By LabPulse.com staff writers
Researchers at Vanderbilt-Ingram Cancer Center evaluated the utility of Oncotype DX (Genomic Health) recurrence scores in 848 men and 110,898 women with early-stage, estrogen receptor-positive (ER+) breast cancer. They used deidentified data from the National Cancer Database, which includes most new cancer cases in the U.S., and noted the recurrence risk score and mortality rate (Clin Cancer Res, November 20, 2019).
November 24, 2019
2019 11 22 21 13 3414 Patient Man 400
Page 1 of 2
Next Page